Amgen (AMGN)

$250.86 1.16 (0.46%)

16:00 EDT AMGN Stock Quote Delayed 30 Minutes

ChemoCentryx (CCXI) Stock Soars 100% on Amgen Acquisition

By William White, InvestorPlace Writer Aug 4, 2022

ChemoCentryx (CCXI) stock is rocketing higher on Thursday as investors react to news of an acquisition deal with Amgen (AMGN).

7 Best Pharmaceutical Stocks to Buy Now

3 Biotech Stocks Outperforming a Bear Market

The 7 Best Biotech Stocks to Buy

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 2.21M

Day's Range $247.63 - $252.01

52-Week Range $198.64 - $258.45

Dividend & Yield $7.04 (2.81%)

AMGN Stock Predictions, Articles, and Amgen News

From InvestorPlace
From the Web

7 Dividend Stocks to Buy for Your Grandkids

By Louis Navellier and the InvestorPlace Research Staff Jun 11, 2022

If this roiling market is making you seasick, then it's an excellent time batten down the hatches with these reliable dividend stocks.

7 Retirement Stocks to Buy to Turbocharge Your Savings

By Chris Markoch May 25, 2022

The best offense is a good defense. Here are seven retirement stocks to buy that combine modest growth with safe dividends.

7 Dividend Stocks to Boost Your Retirement Savings

By Louis Navellier and the InvestorPlace Research Staff May 19, 2022

This is a very good time to look for quality foundational stocks that not only have growth potential but are solid dividend stocks, too.

5 Beaten-Down Blue-Chip Stocks to Buy Now

By Tezcan Gecgil, InvestorPlace Contributor May 17, 2022

These are the best blue-chip stocks to buy now. MMM, AMGN, BA, JPM, and MSFT can make great investments in the coming months.

7 Defensive Dividend Healthcare Stocks to Buy Now

By Louis Navellier and the InvestorPlace Research Staff May 6, 2022

As market conditions remain rocky, adding high-quality healthcare stocks to your portfolio may be a great way to play defense.

What Stocks to Buy That Should Do Well in a Recession — Our 7 Top Picks

By Mark R. Hake, CFA Apr 26, 2022

Americans will still use brand names, buy groceries and clothes, get healthcare services and pay their utilities during a recession. That's good news for these 7 recession-resistant stocks to buy.

Want to Invest Your Tax Refund? 3 Long-Term Stocks to Consider

By Tezcan Gecgil, InvestorPlace Contributor Apr 19, 2022

Here are three of the best long-term stocks to invest in with tax refunds this year

7 Dividend Stocks to Finance Your Golden Years

By Louis Navellier and the InvestorPlace Research Staff Mar 9, 2022

If you're a long-term investor you need top-quality dividend stocks in your portfolio. That doesn't mean big yields as much as reliable ones.

7 Defensive Growth Stocks to Buy for February

By Chris MacDonald, InvestorPlace Contributor Feb 14, 2022

These seven top defensive growth stocks are among the best options for investors looking for growth, but with a risk-off perspective.

Say Hello to 2022’s Dogs of the Dow: 10 Dividend Stocks to Watch

By Tezcan Gecgil, InvestorPlace Contributor Jan 27, 2022

As investor appetite for high-growth stocks begins to decrease in the new year, dividend stocks will likely to gain traction in 2022.

7 Pharmaceutical Stocks That Could Make You Rich

By Tezcan Gecgil, InvestorPlace Contributor Jan 6, 2022

These seven pharmaceutical stocks could create lucrative opportunities in the new year

BAD ETF: The Top “Sin Stock” Holdings in the New Anti-ESG Fund That Debuts Today

By William White, InvestorPlace Writer Dec 22, 2021

There's a new ETF on the block from BAD Investment Company and it seeks to offer investments in sin stocks for interested traders.

7 Drug Stocks to Buy Now While They’re Still on Sale

By Chris Lau, InvestorPlace Contributor Nov 30, 2021

Covid-19 stocks soared to unsustainable highs as investors ignored drug stocks with a deep pipeline of products for the decade ahead.

3 Nasdaq Stocks to Buy and Hold for Years

By David Cohne, StockNews.com Nov 10, 2021

There’s no question that stocks in the Nasdaq composite index have seen massive gains over the last year and a half. Even after taking a back seat to cyclicals late last year, the index continues to hit new heights. That’s why investors should focus on Nasdaq stocks that offer the best long-term prospects. Qualcomm Inc. (QCOM), Amgen Inc. (AMGN), and Workday, Inc. (WDAY) are three that are certainly worth a look.

Penny Biotech Stocks: 8 Things for Verastem Investors to Know as VSTM Stock Shoots Higher

By William White, InvestorPlace Writer Sep 20, 2021

Verastem (VSTM) stock is on the rise Monday morning following an announcement from the company concerning a deal with Amgen (AMGN).

7 Pharmaceutical Stocks To Buy For Valuation Plus Solid Dividends

By Bret Kenwell, InvestorPlace Contributor Apr 29, 2021

High-quality pharmaceutical stocks come with steady business, low valuations and solid dividend. Let's look at a handful of them now.

8 Retirement Stocks to Buy for Any Market Conditions

By Vince Martin, InvestorPlace Contributor Apr 6, 2021

2020 shows that investors need to be prepared for anything. These eight retirement stocks can do precisely that.

FPRX Stock: The Huge Takeover News That Has Five Prime Therapeutics Shares Blasting Higher

By William White, InvestorPlace Writer Mar 4, 2021

Five Prime Therapeutics (FPRX) stock is soaring higher on Thursday following news that Amgen (AMGN) is acquiring the company.

3 Dividend Stocks for Market-Beating Yields and High Growth

By Bob Ciura, Sure Dividend Feb 5, 2021

Sure, dividends are a nice, reliable revenue stream, but they're not the only thing these three dividend stocks have to offer.

The 7 Best Healthcare Stocks to Buy for 2021

By Tom Taulli, InvestorPlace Writer & IPO Playbook Editor Jan 20, 2021

Politics is a wildcard that can negatively impact healthcare stocks. But there are still many top companies with great prospects to consider.

William Blair Remains a Hold on Amgen (AMGN)

From TipRanks Aug 13, 2022

William Blair analyst Matt Phipps maintained a Hold rating on Amgen (AMGN – Research Report) on August 8. The company’s shares closed yesterday at $248....

SVB Securities Sticks to Their Hold Rating for Amgen (AMGN)

From TipRanks Aug 11, 2022

SVB Securities analyst David Risinger maintained a Hold rating on Amgen (AMGN – Research Report) on August 8 and set a price target of $256.00. The company&#8...

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Crispr Therapeutics AG (CRSP) and Annovis Bio (ANVS)

From TipRanks Aug 9, 2022

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Sarepta Therapeutics (SRPT) and Karuna Therapeutics (KRTX)

From TipRanks Aug 9, 2022

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (

Two Appealing Biotech Stocks for Two Distinct investors

From MarketBeat Aug 8, 2022

Investing in biotech stocks carries both risk and reward. This article highlights two biotech companies that may appeal to specific investing styles

Jefferies Keeps Their Buy Rating on Amgen (AMGN)

From TipRanks Aug 8, 2022

In a report released yesterday, Michael Yee from Jefferies maintained a Buy rating on Amgen (AMGN – Research Report), with a price target of $295.00. The comp...